Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting
- 15 November 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 168 (1) , 269-275
Abstract
To validate the newly proposed American Joint Committee on Cancer (AJCC) prognostic staging system for breast cancer.Keywords
This publication has 16 references indexed in Scilit:
- Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilarsThe Breast, 2017
- Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manualCA: A Cancer Journal for Clinicians, 2017
- Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in SwedenThe Breast, 2017
- The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer stagingCA: A Cancer Journal for Clinicians, 2017
- AJCC Cancer Staging Manual2017
- Global Health Equity: Cancer Care Outcome Disparities in High-, Middle-, and Low-Income CountriesJournal of Clinical Oncology, 2016
- Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHERBritish Journal of Cancer, 2014
- Treatment of HER2-positive breast cancerThe Breast, 2014
- Limited M1 Disease: A Significant Prognostic Factor for Stage IV Breast CancerAnnals of Surgical Oncology, 2012
- Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging SystemJournal of Clinical Oncology, 2011